ASTCT Advocacy Statements

ASTCT regularly issues policy statements on a wide range of topics regarding bone marrow transplantation and cellular therapy. Click here to view webinars and other resources related to coverage, coding, billing, and reimbursement. Click on the plus signs below to see docuements and resources within each section. 

Other Letters

2024

Biden Cancer Moonshot Navigation Services Codes

Impact of CMS' NCD for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes

ASTCT CMS Prior Authorization Comment Letter and CMS Responses

ASTCT Comments on Senate HELP Gene Therapy

HSCT for MDS Joint Committee Letter

2023

ASTCT Comment on FDA Draft Guidance on GVHD Drugs

Medicare FY 2025 IPPS DRG Modification Request Letter

ASTCT Statement on U.S. Supreme Court Decision on Affirmative Action

ASTCT Comments on EC and Senate Finance RFI Drug Shortages

ASH, ASTCT, NMDP, CIBMTR and BMT CTN Comments on HSCT for MDS NCA

Medicare Prior Authorization Comment Letter

2022

ASTCT Cost Reporting Instruction Comments

ASTCT, NMDP/Be the Match - FDA Fludarabine Letter

ASTCT - ASH Comment letter on Lymphoma LCD

House Letter: Immunocompromised & COVID-19 Relief Funds

Senate Letter: Immunocompromised & COVID-19 Relief Funds

Joint Letter to Congressional Leadership: Telehealth Flexibilities

Comment Letter to CMS Regarding Split/Shared Evaluation and Management for E/M Visits

Medicare Advantage RFI Response

CY 2023 Medicare Advantage Proposed Rule Comment Letter

Health Future Task Force RFI Response

Comment Letter Regarding the Paperwork Reduction Act Revision of the Hospital and Health Care Complex Cost Report

2021

ASTCT, CIBMTR, NMDP/Be the Match Joint Revaccination Letter to CDC

Palliative Care Act Letter of Support

Vaccine Allocation Letter to CDC

2020

Medicare Coverage of Innovative Technology Comment Letter

Physician Fee Schedule Comment Letter

2019 - Formal Request to CMS on CAR-T Reimbursement Options for FY 2021

2018 - Joint Formal Request to CMS on Coverage and Payment Policies on CAR-T for FY 2020

2017

Formal Request to CMS on CAR-T Payment Policy Options for FY 2019

Letter to CMS to Explore Use of CMMI Authority to Improve CAR-T Reimbursement

Letter to CMS on Exploring New Payment Models for CAR-T

Briefings